Ocuphire Pharma Inc Forecast, price target & analysts
Ocuphire Pharma Inc Target price 2025 - Analyst rating & recommendation
Ocuphire Pharma Inc Classifications & Recommendation:
Ocuphire Pharma Inc Price Target
| Target Price | $9.00 |
| Price | $1.04 |
| Potential |
765.39%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Ocuphire Pharma Inc 2026 .
The average Ocuphire Pharma Inc target price is $9.00.
This is
765.39%
register free of charge
$10.00
861.54%
register free of charge
$8.00
669.23%
register free of charge
|
|
| A rating was issued by 3 analysts: 3 Analysts recommend Ocuphire Pharma Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ocuphire Pharma Inc stock has an average upside potential 2026 of
765.39%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 19.05 | 17.80 |
| 52.20% | 6.56% | |
| Net Margin | -63.27% | -150.13% |
| 210.60% | 137.30% |
3 Analysts have issued a sales forecast Ocuphire Pharma Inc 2024 . The average Ocuphire Pharma Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Ocuphire Pharma Inc 2024 . The average Ocuphire Pharma Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.46 | -1.02 |
| 152.87% | 121.74% | |
| P/E | negative | |
| EV/Sales | negative |
1 Analysts have issued a Ocuphire Pharma Inc forecast for earnings per share. The average Ocuphire Pharma Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Ocuphire Pharma Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Ocuphire Pharma Inc...
Current Ocuphire Pharma Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Feb 19 2025 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Feb 19 2025 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
